1) 日本排尿機能学会 過活動膀胱診療ガイドライン作成委員会(編) : 過活動膀胱診療ガイドライン 第2版. pp208─215, リッチヒルメディカル, 東京, 2015
2) Gormley EA, Lightner DJ, Faraday M, et al : Diagnosis and treatment of overactive bladder(non-neurogenic)in adults : AUA/SUFU guideline amendment. J Urol 193 : 1572─1580, 2015
3) Schwanttes U, Grosse J and Wiedemann A : Refractory overactive bladder : a common problem? Int Urogynecol J 26 : 1407─1414, 2015
4) Trocio JN, Brubaker L, Schabert VF, et al : Fesoterodine prescription fill patterns and the YourWay patient support plan for patients with overactive baldder symptoms and physicians. Postgrad Med 126 : 246─256, 2014
5) Kaplan AS, Cardozo L, Hershorn S, et al : Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER. Int J Clin Pract 68 : 1065─1073, 2014
6) Chancellor MB, Zinner N, Whitemore K, et al : Efficacy of solifenacin in patients previously treated with tolterodine extended relase 4 mg : results of 12-week, multicenter, open-label, flexible-dose study. Clin Ther 30 : 1776─1781, 2008
7) Masumori N, Miyamoto S, Tsukamoto T, et al : The efficacy and safety of propiverine hydrochloride in patients with overactive bladder symptoms who poorly responded to previous anticholinergic agents. Adv Urol 2011[Epub 2011 June 8]
8) Yamaguchi O, Uchida E, Higo N, et al : Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder : A randomized double-blind trial. Int J Urol 21 : 586─593, 2014
9) 上掲1), pp35─37
10) Yamaguchi O, Kakizaki H, Homma Y, et al : Safety and efficacy of mirabegron as ‘add-on’ therapy in patients with overactive bladder treated with solifenacin : a post-marketing, open-label study in Japan(MILAI study).BJUint 116 : 612─622, 2015
11) http://www.aua2015.org/abstracts/searchabstracts.cfmでPII-LBA9で検索
12) 上掲1), pp50─51
13) Bartley J, Gilleran J and Peters K : Neuromodulation for overactive bladder. Nat Rev Urol 10 : 513─521, 2013
14) 上掲1), pp49─50
15) 上掲1), pp170─174
16) Karmarkar R and Khullar V : Emerging drugs for overactive bladder. Expert Opin Emerging Drugs 2015[Epub ahead of print]